PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Methylene chloride/methanol root bark extract significantly reduced blood glucose, serum cholesterol, triglyceride, creatinine, and urea in streptozotocin-induced diabetic rats [PMID: 20162071].
Ethanolic bark extract (200 mg/kg) significantly decreased blood glucose levels in streptozotocin-induced diabetic rats [PMID: 24391227].
Ethyl acetate extract, alone and in combination with doxorubicin, improved liver-function biochemical markers (ALT, AST, GGT, ALP) and tumor marker (AFP-L3) in a rat model [PMID: 38370475].
Cinchonain Ia showed a 91% inhibitory effect on amyloid β42 aggregation [PMID: 32151639].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36432208 (2022) — Biobased Kapok Fiber Nano-Structure for Energy and Environment Application: A Critical Review. · Molecules (Basel, Switzerland)
- 2.PMID: 25597659 (2015) — Research and application of kapok fiber as an absorbing material: a mini review. · Journal of environmental sciences (China)
- 3.PMID: 35214854 (2022) — The Biology of the Genus Ceiba, a Potential Source for Sustainable Production of Natural Fiber. · Plants (Basel, Switzerland)
- 4.PMID: 33957461 (2021) — Ceiba pentandra cellulose crosslinked with citric acid for drug release systems. · Carbohydrate research
- 5.PMID: 35270400 (2022) — Modification Strategies of Kapok Fiber Composites and Its Application in the Adsorption of Heavy Metal Ions and Dyes from Aqueous Solutions: A Systematic Review.